Atlas Trials

A Study to Evaluate the Relative Bioavailability, Effect of Food, and Gastric Potential Hydrogen (pH) Modification on the Pharmacokinetics of TAK-117 (MLN1117) in Healthy Participants

Clinical trial NCT02625259 · COMPLETED

Trial details

NCT number
NCT02625259
Sponsor
Millennium Pharmaceuticals, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Neoplasm, Advanced or Metastatic
Start date
2016-01-08
Primary completion
2016-05-16
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.